| Title |
Author |
Region |
Reference |
Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: The IeDEA Southern Africa collaboration
[more]
|
Cornell M, Technau K, Fairall L, Wood R, Moultrie H, van Cutsem G, Giddy J, Mohapi L, Eley B, MacPhail P, Prozesky H, Rabie H, Davies MA, Maxwell N, Boulle A; International epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration |
Southern Africa |
SAMJ Sept 2009, Vol. 99, No. 9 |
Mortality of Patients Lost to Follow-Up in Antiretroviral Treatment Programmes in Resource-Limited Settings: Systematic Review and Meta-Analysis
[more]
|
Martin W. G. Brinkhof, Mar Pujades-Rodriguez, Matthias Egger |
Southern Africa |
PLoS ONE 4(6): e5790. doi:10.1371/journal.pone.0005790 |
Outcomes of the South African National Antiretroviral Treatment (ART) programme for children - the IeDEA Southern Africa Collaboration
[more]
|
Mary-Ann Davies, Olivia Keiser, Karl Technau, Brian Eley, Helena Rabie, Gilles Van Cutsem, Janet Giddy, Robin Wood, Andrew Boulle, Matthias Egger, Harry Moultrie |
Southern Africa |
S Afr Med J. 2009 Oct;99(10):730-37 |
Authors' response: the importance of asking the right question
[more]
|
Keiser O, Egger M |
Southern Africa |
Trop Med Int Health. 2010 Jan 11. [Epub ahead of print] |
Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa
[more]
|
Fenner L, Brinkhof MW, Keiser O, Weigel R, Cornell M, Moultrie H, Prozesky H, Technau K, Eley B, Vaz P, Pascoe M, Giddy J, Van Cutsem G, Wood R, Egger M, Davies MA; for the International epidemiologic Databases to Evaluate AIDS in Southern Africa (IeDEA-SA) |
Southern Africa |
J Acquir Immune Defic Syndr. 2010 Aug 15;54(5):524-32 |
Assessing the contribution of the immune reconstitution inflammatory syndrome to mortality in developing country antiretroviral therapy programs (Editorial)
[more]
|
Davies MA, Egger M, Keiser O and Boulle A |
Southern Africa |
Clin Infect Dis. 2009 September 15; 49(6): 973-975 |
Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort.
[more]
|
Boulle A, Orrel C, Kaplan R, Van Cutsem G, McNally M, Hilderbrand K, Myer L, Egger M, Coetzee D, Maartens G, Wood R; International Epidemiological Databases to Evaluate Aids in Southern Africa Collaboration |
Southern Africa |
Antivir Ther. 2007;12(5):753-60. |
Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared.
[more]
|
Keiser O, Orrell C, Egger M, Wood R, Brinkhof MW, Furrer H, van Cutsem G, Ledergerber B, Boulle A; Swiss HIV Cohort Study (SHCS) and the International Epidemiologic Databases to Evaluate AIDS in Southern Africa (IeDEA-SA) |
Southern Africa |
PLoS Med. 2008 Jul 8;5(7):e148. |
Paediatric antiretroviral treatment programmes in sub-Saharan Africa: a review of published clinical studies
[more]
|
Davies MA, Egger, M, Keiser O, Boulle A |
Southern Africa |
African Journal of AIDS Research 2009, 8(3):329-338 |
Growth response to antiretroviral treatment in HIV-infected children: a cohort study from Lilongwe, Malawi.
[more]
|
Weigel R, Phiri S, Chiputula F, Gumulira J, Brinkhof M, Gsponer T, Tweya H, Egger M, Keiser O |
Southern Africa |
Trop Med Int Health. 2010 Jun 15 [Epub ahead of print] |